Trial Profile
Single-Site, Open-Label, Randomized, Cross-Over Trial to Evaluate the Bioequivalence of Single Dose Rotigotine Transdermal Patch (4.5mg/10cm2) From 2 Different Manufacturing Processes.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Oct 2014
Price :
$35
*
At a glance
- Drugs Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors UCB
- 28 Apr 2009 New trial record